{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:55:37Z","timestamp":1785556537093,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09538-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:05:55Z","timestamp":1768521955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting PAK4 promotes Gemcitabine-induced pyroptosis in pancreatic cancer via NLRP1\/caspase-3\/GSDME axis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4521-6380","authenticated-orcid":false,"given":"Tianqi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8348-230X","authenticated-orcid":false,"given":"Xiaodong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-2027","authenticated-orcid":false,"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-7456","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"9538_CR1","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.18632\/aging.204310","volume":"14","author":"S Jiang","year":"2022","unstructured":"Jiang, S. et al. A comprehensive review of pancreatic cancer and its therapeutic challenges. Aging 14, 7635\u20137649 (2022).","journal-title":"Aging"},{"key":"9538_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607\u2013620 (2011).","journal-title":"Lancet"},{"key":"9538_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos, J. P. et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat. Rev. Gastroenterol. Hepatol. 15, 333\u2013348 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9538_CR4","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris","year":"1997","unstructured":"Burris, H. A. et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 15, 2403\u20132413 (1997).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"9538_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","volume":"21","author":"TF Stoop","year":"2024","unstructured":"Stoop, T. F. et al. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 21, 101\u2013124 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9538_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers, C. et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat. Commun. 8, 14128 (2017).","journal-title":"Nat. Commun."},{"key":"9538_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","volume":"27","author":"SB Kovacs","year":"2017","unstructured":"Kovacs, S. B. & Miao, E. A. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 27, 673\u2013684 (2017).","journal-title":"Trends Cell Biol."},{"key":"9538_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tcb.2021.03.004","volume":"31","author":"E De Schutter","year":"2021","unstructured":"De Schutter, E. et al. Punching holes in cellular membranes: biology and evolution of gasdermins. Trends Cell Biol. 31, 500\u2013513 (2021).","journal-title":"Trends Cell Biol."},{"key":"9538_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu, P. et al. Pyroptosis: mechanisms and diseases. Signal. Transduct. Target Ther. 6, 128 (2021).","journal-title":"Signal. Transduct. Target Ther."},{"key":"9538_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"9538_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41590-022-01199-x","volume":"23","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. KSHV-encoded ORF45 activates human NLRP1 inflammasome. Nat. Immunol. 23, 916\u2013926 (2022).","journal-title":"Nat. Immunol."},{"key":"9538_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"9538_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06382-y","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles. Cell Death Dis. 14, 836 (2023).","journal-title":"Cell Death Dis."},{"key":"9538_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-00349-0","volume":"6","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Qi, L., Li, L. & Li, Y. The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov. 6, 112 (2020).","journal-title":"Cell Death Discov."},{"key":"9538_CR15","first-page":"4349","volume":"58","author":"JR Mackey","year":"1998","unstructured":"Mackey, J. R. et al. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 58, 4349\u20134357 (1998).","journal-title":"Cancer Res."},{"key":"9538_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1078-0432.CCR-07-2247","volume":"14","author":"MP Kim","year":"2008","unstructured":"Kim, M. P. & Gallick, G. E. Gemcitabine resistance in pancreatic cancer: picking the key players. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 14, 1284\u20131285 (2008).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"9538_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4143\/crt.2014.054","volume":"47","author":"SU Moon","year":"2015","unstructured":"Moon, S. U. et al. p21-activated kinase 4 (PAK4) as a predictive marker of gemcitabine sensitivity in pancreatic cancer cell lines. Cancer Res. Treat. 47, 501\u2013508 (2015).","journal-title":"Cancer Res. Treat."},{"key":"9538_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2018.01.006","volume":"54","author":"CK Rane","year":"2019","unstructured":"Rane, C. K. & Minden, A. P21 activated kinase signaling in cancer. Semin. Cancer Biol. 54, 40\u201349 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"9538_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41418-021-00828-6","volume":"29","author":"C Huang","year":"2022","unstructured":"Huang, C. et al. CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating \u03b2-catenin\/ MEK-ERK signaling pathway. Cell Death Differ. 29, 14\u201327 (2022).","journal-title":"Cell Death Differ."},{"key":"9538_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106041","volume":"138","author":"TDF Costa","year":"2021","unstructured":"Costa, T. D. F. & Str\u00f6mblad, S. Why is PAK4 overexpressed in cancer? Int. J. Biochem. Cell Biol. 138, 106041 (2021).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"9538_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1593\/neo.04130","volume":"6","author":"EH Mahlam\u00e4ki","year":"2004","unstructured":"Mahlam\u00e4ki, E. H. et al. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. Neoplasia 6, 432\u2013439 (2004).","journal-title":"Neoplasia"},{"key":"9538_CR22","doi-asserted-by":"publisher","first-page":"14414","DOI":"10.1074\/jbc.M011046200","volume":"276","author":"N Gnesutta","year":"2001","unstructured":"Gnesutta, N., Qu, J. & Minden, A. The serine\/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414\u201314419 (2001).","journal-title":"J. Biol. Chem."},{"key":"9538_CR23","doi-asserted-by":"publisher","first-page":"12740","DOI":"10.18632\/aging.103173","volume":"12","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. PAK4 suppresses TNF-induced release of endothelial microparticles in HUVECs cells. Aging 12, 12740\u201312749 (2020).","journal-title":"Aging"},{"key":"9538_CR24","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.molcel.2022.04.033","volume":"82","author":"R Plan\u00e8s","year":"2022","unstructured":"Plan\u00e8s, R. et al. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol. Cell 82, 2385\u20132400.e2389 (2022).","journal-title":"Mol. Cell"},{"key":"9538_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36614-w","volume":"14","author":"Y Wei","year":"2023","unstructured":"Wei, Y. et al. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis. Nat. Commun. 14, 929 (2023).","journal-title":"Nat. Commun."},{"key":"9538_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s10020-024-00831-w","volume":"30","author":"X Xu","year":"2024","unstructured":"Xu, X. & Qiu, H. BRD4 promotes gouty arthritis through MDM2-mediated PPAR\u03b3 degradation and pyroptosis. Mol. Med. 30, 67 (2024).","journal-title":"Mol. Med."},{"key":"9538_CR27","doi-asserted-by":"publisher","first-page":"e2820","DOI":"10.1038\/cddis.2017.85","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Cell Death Dis. 8, e2820\u2013e2820 (2017).","journal-title":"Cell Death Dis."},{"key":"9538_CR28","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1074\/jbc.M112.384289","volume":"288","author":"T Liu","year":"2013","unstructured":"Liu, T. et al. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J. Biol. Chem. 288, 3359\u20133369 (2013).","journal-title":"J. Biol. Chem."},{"key":"9538_CR29","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.1073\/pnas.0911863107","volume":"107","author":"BW Murray","year":"2010","unstructured":"Murray, B. W. et al. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc. Natl. Acad. Sci. USA 107, 9446\u20139451 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9538_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41586-024-07379-z","volume":"629","author":"UN Wasko","year":"2024","unstructured":"Wasko, U. N. et al. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature 629, 927\u2013936 (2024).","journal-title":"Nature"},{"key":"9538_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.307","volume":"4","author":"R Hill","year":"2013","unstructured":"Hill, R. et al. Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy. Cell Death Dis. 4, e791 (2013).","journal-title":"Cell Death Dis."},{"key":"9538_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216206","volume":"564","author":"S Li","year":"2023","unstructured":"Li, S. et al. Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Lett. 564, 216206 (2023).","journal-title":"Cancer Lett."},{"key":"9538_CR33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-24-3149","volume":"31","author":"B Ardalan","year":"2025","unstructured":"Ardalan, B. et al. Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 31, 1082\u20131090 (2025).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"9538_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10891-0","volume":"7","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Cell division cycle 42 plays a cell type-specific role in lung tumorigenesis. Sci. Rep. 7, 10407 (2017).","journal-title":"Sci. Rep."},{"key":"9538_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507533","volume":"12","author":"X Ji","year":"2025","unstructured":"Ji, X. et al. Novel evolutionarily conserved oncogene COA4 is driven by KRAS mutant and promotes cancer metastasis through dual mitochondrial metabolism-dependent and -independent mechanisms. Adv. Sci. 12, e07533 (2025).","journal-title":"Adv. Sci."},{"key":"9538_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1158\/1541-7786.MCR-12-0466","volume":"11","author":"H Tabusa","year":"2013","unstructured":"Tabusa, H., Brooks, T. & Massey, A. J. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF\/MEK\/ERK and PI3K\/AKT signaling. Mol. Cancer Res. 11, 109\u2013121 (2013).","journal-title":"Mol. Cancer Res."},{"key":"9538_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4161\/cl.21882","volume":"2","author":"DZ Ye","year":"2012","unstructured":"Ye, D. Z. & Field, J. PAK signaling in cancer. Cell. Logist. 2, 105\u2013116 (2012).","journal-title":"Cell. Logist."},{"key":"9538_CR38","doi-asserted-by":"publisher","unstructured":"Fenini, G., Karakaya, T., Hennig, P., Di Filippo, M. & Beer, H. D. The NLRP1 inflammasome in human skin and beyond. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21134788 (2020).","DOI":"10.3390\/ijms21134788"},{"key":"9538_CR39","doi-asserted-by":"publisher","unstructured":"Bauernfried, S., Scherr, M. J., Pichlmair, A., Duderstadt, K. E. & Hornung, V. Human NLRP1 is a sensor for double-stranded RNA. Science 371, https:\/\/doi.org\/10.1126\/science.abd0811 (2021).","DOI":"10.1126\/science.abd0811"},{"key":"9538_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2021.07.014","volume":"520","author":"L Li","year":"2021","unstructured":"Li, L. et al. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2\/caspase-8\/caspase-3\/GSDME axis. Cancer Lett. 520, 143\u2013159 (2021).","journal-title":"Cancer Lett."},{"key":"9538_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109967","volume":"361","author":"RY Li","year":"2022","unstructured":"Li, R. Y. et al. Cisplatin-induced pyroptosis is mediated via the CAPN1\/CAPN2-BAK\/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer. Chem. Biol. Interact. 361, 109967 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"9538_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296\u2013299 (1997).","journal-title":"Nature"},{"key":"9538_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res."},{"key":"9538_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-018-0128-9","volume":"557","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing. Nature 557, 585\u2013589 (2018).","journal-title":"Nature"},{"key":"9538_CR45","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/s41418-020-0568-2","volume":"27","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. USP22 positively modulates ER\u03b1 action via its deubiquitinase activity in breast cancer. Cell Death Differ. 27, 3131\u20133145 (2020).","journal-title":"Cell Death Differ."},{"key":"9538_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2016.09.014","volume":"64","author":"F Ohtake","year":"2016","unstructured":"Ohtake, F., Saeki, Y., Ishido, S., Kanno, J. & Tanaka, K. The K48-K63 branched ubiquitin chain regulates NF-\u03baB signaling. Mol. cell 64, 251\u2013266 (2016).","journal-title":"Mol. cell"},{"key":"9538_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-051810-094654","volume":"81","author":"K Husnjak","year":"2012","unstructured":"Husnjak, K. & Dikic, I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291\u2013322 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"9538_CR48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 12, 945 (2021).","journal-title":"Cell Death Dis."},{"key":"9538_CR49","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/nar\/gkq006","volume":"38","author":"Y Shao","year":"2010","unstructured":"Shao, Y. et al. Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX. Nucleic Acids Res. 38, 2813\u20132824 (2010).","journal-title":"Nucleic Acids Res."},{"key":"9538_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biocel.2009.09.008","volume":"42","author":"X Li","year":"2010","unstructured":"Li, X. et al. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cells via LIMK1. Int. J. Biochem. Cell Biol. 42, 70\u201379 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"9538_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06908-y","volume":"15","author":"Y He","year":"2024","unstructured":"He, Y. et al. MORC2 regulates RBM39-mediated CDK5RAP2 alternative splicing to promote EMT and metastasis in colon cancer. Cell Death Dis. 15, 530 (2024).","journal-title":"Cell Death Dis."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09538-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09538-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09538-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:10:59Z","timestamp":1771434659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09538-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9538"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09538-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}